Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibrinolytic therapy.

E C Klatte, G J Becker, R E Holden

    Radiology
    |June 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Fibrinolytic therapy is rapidly evolving, with current treatments showing excellent results. Future advancements in fibrinolysis promise even greater impacts on healthcare.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Usefulness of mean platelet volume as a marker for clinical outcomes after out-of-hospital cardiac arrest: a retrospective cohort study.

    Journal of thrombosis and haemostasis : JTH·2016
    Same author

    Hypercalcaemia--rapid relief.

    Internal medicine journal·2010
    Same author

    Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions.

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2008
    Same author

    Thrombin is a pro-fibrotic factor for rat renal fibroblasts in vitro.

    Nephron. Experimental nephrology·2005
    Same author

    Resolution of pure red cell aplasia with continued production of low titer anti-epoetin antibodies.

    Clinical nephrology·2005
    Same author

    Intracellular cyclic nucleotide analogues inhibit in vitro mitogenesis and activation of fibroblasts derived from obstructed rat kidneys.

    Nephron. Experimental nephrology·2004
    Same journal

    Noncontrast Abbreviated MRI for Post-TACE Treatment Response Monitoring of Hepatocellular Carcinoma Based on Ancillary Features from LI-RADS.

    Radiology·2026
    Same journal

    Response Evaluation Criteria in Bone Metastases: Performance and Association of Response Classifications with Survival Outcomes.

    Radiology·2026
    Same journal

    Entropy for Prediction of MACEs in Myocarditis: A Cardiac MRI-based Biomarker of Myocardial Tissue Heterogeneity.

    Radiology·2026
    Same journal

    AI for Radiology: A Primer Part II. Interacting with AI Results.

    Radiology·2026
    Same journal

    Hyperdense Capsule Sign at Noncontrast CT as an Indication for Middle Meningeal Artery Embolization for Nonacute Subdural Hematomas: A MAGIC-MT Trial Post Hoc Analysis.

    Radiology·2026
    Same journal

    Sawtooth Cardiomyopathy: The Tiger Heart.

    Radiology·2026
    See all related articles

    Area of Science:

    • Cardiovascular Medicine
    • Hematology
    • Pharmacology

    Background:

    • Fibrinolytic therapy is a rapidly advancing field in medicine.
    • Expert opinions on fibrinolysis vary, highlighting ongoing debates and research.
    • Objective data are accumulating, but the field's future remains dynamic due to new developments.

    Purpose of the Study:

    • To present the current status of fibrinolytic therapy from the authors' perspective.
    • To discuss the evolving landscape and future potential of fibrinolysis.
    • To highlight the impact of ongoing research and development in this area.

    Main Methods:

    • Review of current literature and expert viewpoints on fibrinolysis.
    • Analysis of emerging trends and novel compounds in fibrinolytic therapy.

    Related Experiment Videos

  • Synthesis of objective data to assess the present and future state of the field.

    • Main Results:

    • Current fibrinolytic therapies yield excellent clinical outcomes.
    • Newer compounds and techniques are expected to significantly surpass existing treatments.
    • The field is characterized by rapid innovation and continuous change.

    Conclusions:

    • Fibrinolytic therapy is a dynamic and rapidly progressing area of medical science.
    • Future developments in fibrinolysis are anticipated to revolutionize patient care.
    • Continued research and development are crucial for advancing healthcare delivery through improved fibrinolytic strategies.